Stock Markets21 hours ago (Jan 14, 2022 08:30AM ET)
By Dhirendra Tripathi
Investing.com – Shares of companies making Covid vaccines were taking a knock in premarket trading a day after the U.S. Supreme Court blocked the Biden administration’s workplace vaccine-or-test mandate for larger private employers.
Novavax (NASDAQ:NVAX) stock took the biggest hit, losing more than 10%. The company is more than a year behind bringing a vaccine to the market and is yet to seek FDA’s nod for emergency use. It has secured the nod from WHO and in U.K., the E.U., India and in a few more countries.
BioNTech (NASDAQ:BNTX) lost 5% while its partner, Pfizer (NYSE:PFE), fell 1.6%. Moderna (NASDAQ:MRNA) was down 5.4% while Johnson & Johnson (NYSE:JNJ), the least affected since it draws only minuscule revenue from the vaccines, shed 0.6%.
The conditions for businesses with 100 or more employees would have applied to an estimated 84 million workers. The court ruled the administration didn’t have the unilateral power to impose a mandate that employers ensure their workers are vaccinated or tested every week to detect coronavirus.
The ruling comes at a time when omicron, the most contagious of the coronavirus variants, has led to record infections in the U.S. and elsewhere in the world. According to New York Times, an average of more than 803,000 coronavirus cases have been reported each of the last seven days in the U.S., an increase of 133% from two weeks ago.
Corporates, after keeping offices shut for almost two years, are beginning to reopen workplaces while a large number of their workers remain reluctant to get the vaccine.
Vaccine-Makers Hit as Supreme Court Blocks Vaccine-or-Test Mandate
AMSTERDAM (Reuters) – Apple (NASDAQ:AAPL) said on Saturday it would allow developers of dating apps in the Netherlands to offer non-Apple payment options to their users, complying…
By Aditi Shah NEW DELHI (Reuters) – India, which has among the world’s deadliest roads, on Saturday proposed mandating at least six air bags in all passenger cars manufactured…
By Diane Bartz and Elizabeth Culliford WASHINGTON (Reuters) – Multiple states have begun investigating potential violations in how Facebook (NASDAQ:FB), now known as Meta…
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
(C) 2007-2022 Fusion Media Limited. All Rights Reserved
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.